Literature DB >> 27460803

Structural Mechanisms in NLR Inflammasome Assembly and Signaling.

Zehan Hu1, Jijie Chai2.   

Abstract

Inflammasomes are multimeric protein complexes that mediate the activation of inflammatory caspases. One central component of inflammasomes is nucleotide-binding domain (NBD)- and leucine-rich repeat (LRR)-containing proteins (NLRs) that can function as pattern recognition receptors (PRRs). In resting cells, NLR proteins exist in an auto-inhibited, monomeric, and ADP-bound state. Perception of microbial or damage-associated signals results in NLR oligomerization, thus recruiting inflammatory caspases directly or through the adaptor molecule apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC). The assembled NLR inflammasomes serve as dedicated machinery to facilitate the activation of the inflammatory caspases. Here, we review current understanding of the structures of NLR inflammasomes with an emphasis on the molecular mechanisms of their assembly and activation. We also discuss implications of the self-propagation model derived from the NAIP-NLRC4 inflammasomes for the activation of other NLR inflammasomes and a potential role of the C-terminal LRR domain in the activation of an NLR protein.

Entities:  

Keywords:  Assembly and signaling; Inflammasomes; NOD-like receptors; Structural mechanisms

Mesh:

Substances:

Year:  2016        PMID: 27460803     DOI: 10.1007/978-3-319-41171-2_2

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  11 in total

1.  A genetic origin for acid-base imbalance triggers the mitochondrial damage that explains the autoimmune response and drives to gastric neuroendocrine tumours.

Authors:  Javier Benítez; Roberta Marra; José Reyes; Oriol Calvete
Journal:  Gastric Cancer       Date:  2019-06-27       Impact factor: 7.370

Review 2.  COPs and POPs Patrol Inflammasome Activation.

Authors:  Mohanalaxmi Indramohan; Christian Stehlik; Andrea Dorfleutner
Journal:  J Mol Biol       Date:  2017-10-10       Impact factor: 5.469

Review 3.  NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes.

Authors:  Ilona M Gora; Anna Ciechanowska; Piotr Ladyzynski
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

Review 4.  RNA sensors of the innate immune system and their detection of pathogens.

Authors:  Nanhua Chen; Pengpeng Xia; Shuangjie Li; Tangjie Zhang; Tony T Wang; Jianzhong Zhu
Journal:  IUBMB Life       Date:  2017-04-04       Impact factor: 3.885

5.  Azeliragon ameliorates Alzheimer's disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway.

Authors:  Lijuan Yang; Yepei Liu; Yuanyuan Wang; Junsheng Li; Na Liu
Journal:  Clinics (Sao Paulo)       Date:  2021-03-08       Impact factor: 2.365

Review 6.  Inflammasomes and Fibrosis.

Authors:  Wen-Juan Zhang; Shu-Juan Chen; Shun-Chang Zhou; Su-Zhen Wu; Hui Wang
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

Review 7.  NLRC5: A Potential Target for Central Nervous System Disorders.

Authors:  Lu Zhang; Cui Jiao; Lingjuan Liu; Aiping Wang; Li Tang; Yi Ren; Peng Huang; Jie Xu; Dingan Mao; Liqun Liu
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

Review 8.  Diverse pro-inflammatory endotoxin recognition systems of mammalian innate immunity.

Authors:  Jerrold Weiss; Jason Barker
Journal:  F1000Res       Date:  2018-04-30

Review 9.  NLRP3 Inflammasome and Inflammatory Diseases.

Authors:  Zheng Wang; Simei Zhang; Ying Xiao; Wunai Zhang; Shuai Wu; Tao Qin; Yangyang Yue; Weikun Qian; Li Li
Journal:  Oxid Med Cell Longev       Date:  2020-02-17       Impact factor: 6.543

Review 10.  GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy.

Authors:  Yi Zuo; Li Chen; Huiping Gu; Xiaoyun He; Zhen Ye; Zhao Wang; Qixiang Shao; Caiping Xue
Journal:  Expert Rev Mol Med       Date:  2021-12-27       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.